Global Cord Blood Corporation (CORBF)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
Sep 15, 2025, 8:00 PM EDT
Global Cord Blood Market Cap
Global Cord Blood has a market cap or net worth of $133.91 million as of September 17, 2025. Its market cap has decreased by -31.51% in one year.
Market Cap
133.91M
Enterprise Value
n/a
Revenue
196.10M
Ranking
n/a
PE Ratio
1.54
Stock Price
$1.00
Market Cap Chart
Since July 1, 2009, Global Cord Blood's market cap has decreased from 968.15M to 133.91M, a decrease of -86.17%. That is a compound annual growth rate of -11.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 133.91M | -33.33% |
| Dec 31, 2024 | 200.87M | 22.95% |
| Dec 29, 2023 | 163.38M | -67.92% |
| Dec 31, 2021 | 509.30M | 12.94% |
| Dec 31, 2020 | 450.95M | -25.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 792.01M |
| Elite Pharmaceuticals | 718.26M |
| Glass House Brands | 567.62M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |